Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 10;72(10):3217–3228. doi: 10.1007/s00262-023-03489-1

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

PMC Copyright notice

Fig. 4 — Overall survival depending on significant clinical variables. a type of cancer diagnosis: others versus lung cancer; b metastatic extent of disease: 1 site versus ≥ 2 sites; c programmed cell death-ligand 1 tumor proportion score (PD-L1 TPS): ≥ 1% versus unknown or < 1%; d level of antibody response: Low-R (subgroup of patients with an anti-RBD-S1 IgG titer < 486 BAU/mL after the third dose of vaccine) versus High-R (subgroup of patients with an anti-RBD-S1 IgG titer ≥ 486 BAU/mL after the third dose of vaccine)